June 20, 2022
Ascendia Pharmaceuticals CEO Jim Huang, PhD, presented at the Greater Philadelphia Chapter of the Sino-American Pharmaceutical Professionals Association (SAPA) event. […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
April 21, 2022
There are two options for oral-solid dosage drugs: tablets and capsules. Because tablets are simply a compressed solid form of […]
READ MORE >April 14, 2022
Capsules are a common oral dosage formulation favored by both consumers and pharmaceutical companies. While consumers appreciate that capsules are […]
READ MORE >